Subscribe to Updates
Subscribe to our newsletter and never miss our latest news
Subscribe my Newsletter for New Posts & tips Let's stay updated
Subscribe to our newsletter and never miss our latest news
Subscribe my Newsletter for New Posts & tips Let's stay updated
A Nike logo is displayed at a Nike store on Feb. 5, 2026 in Austin, Texas.Brandon Bell | Getty ImagesNike is expected to report a steep decline in quarterly profit and flat sales on Tuesday as the sneaker giant continues to work through a colossal turnaround under CEO Elliott Hill. About a year and a half into his tenure, Hill has made strides in repairing parts of the business, but has been clear that it’ll take time for the entire company to improve given the retailer’s scale and complexity. When reporting fiscal second-quarter results in December, Nike said sales rose 9% in…
The U.S. Supreme Court is seen on March 4 in Washington, D.C. Kevin Dietsch/Getty Images hide caption toggle caption Kevin Dietsch/Getty Images The Supreme Court has ruled that Colorado’s law banning conversion therapy “regulates speech based on viewpoint.” At issue was the practice of an Evangelical Christian, Kaley Chiles, a counselor who wants to provide talk therapy to teenagers seeking to discuss their sexual orientation or gender identity, including those hoping to “reduce or eliminate unwanted sexual attractions, change sexual behaviors, or grow in the experience of harmony with one’s physical body,” according to her complaint. Her lawyer argued that…
Jamie Dimon wants his bank to save the American dream at a moment when many Americans are losing faith in its economic promise. JPMorgan announced a sweeping initiative aimed at expanding opportunities for upward mobility on Tuesday. It’s “American Dream Initiative” will focus on six key areas: small-business growth, housing affordability, financial literacy, skills-based training, healthcare, and local institutions, such as schools and hospitals. Loading audio narration… While JPMorgan CEO Dimon, who made $43 million last year, is bullish on the American promise, Americans themselves are increasingly skeptical that capitalism, at its heart, still works. A Gallup poll in September found…
The sun is going down on a sub-freezing afternoon in New York City. Loading audio narration… The 21-year-old media executive Rowan Winch is bundled up alongside a gaggle of 20-somethings shooting a TikTok in Washington Square Park.”I try not to get too involved,” Winch told me, as he stood out of the frame of the shot.His favorite part on set? Watching the production unfold.”Even if I’m not directly filming it, I can see how this is going to work,” Winch said. Winch’s company, Fallen Media, launched in 2020, just as short-form video content was taking off. The creator economy was…
Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug for excessive daytime sleepiness, the company said Tuesday.Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult for people to stay awake during the day. The drugs may also be used to treat other neurological conditions that are accompanied by drowsiness, such as Alzheimer’s disease and depression, and possibly even more broadly.Other possibilities include another severe sleep disorder called idiosyncratic hypersomnia, as well as other conditions where people experience sleepiness…
“Project Hail Mary” is setting records for Amazon MGM and lighting the path for a box-office revitalization.The science fiction flick, starring Ryan Gosling, has tallied more than $300 million globally since its theatrical opening two weeks ago. That marks the best performance for an Amazon MGM film ever.”The runaway success of ‘Project Hail Mary’ represents a key turning point for Amazon MGM giving the distributor its first $100 million plus domestic box office earner,” said Paul Dergarabedian, head of marketplace trends at Comscore.”Project Hail Mary” has held notably strong at the box office since its debut, with only a 32%…
McCormick will buy Unilever’s food business for a combination of cash and equity, in a deal that values the Unilever unit at nearly $45 billion, the two food companies announced.To purchase most of Unilever Foods’ portfolio, including Hellmann’s mayo and U.K. favorite Marmite, McCormick will pay $15.7 billion in cash. Unilever shareholders will own 55.1% of the combined company, while Unilever will hold a 9.9% stake.The deal will add billions of dollars in annual sales for McCormick and expand the spice giant’s portfolio further into spreads and condiments. It already owns Frank’s RedHot and Cholula hot sauces and French’s mustard…
A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox.Refinancing a home loan has long been a complicated and pricey process. The costs can be so high that most experts suggest if a borrower can’t shave at least 75 basis points off their current mortgage interest rate, the refinance isn’t even worth it. Now two property tech leaders…
“How much does this cost?” has become a surprisingly complicated question. Loading audio narration… The rise of e-commerce, algorithmic pricing, and black-box systems has left consumers feeling like they’re playing roulette when they buy something.To show how unpredictable the process can feel, BI’s Juliana Kaplan conducted an experiment. She tracked price changes over 14 days for a handful of items she left in her digital Old Navy cart. The prices fluctuated so much that Juliana dubbed herself a “leggings day trader.”It’s not the first time BI has tried to uncover the quirks of online pricing.A few weeks ago, BI’s Peter…
Wegovy semaglutide tablets.Michael Siluk | Universal Images Group | Getty ImagesNovo Nordisk on Tuesday launched a multi-month subscription program for its Wegovy obesity drug products that aims to ensure cash-paying patients see lower, “predictable” monthly prices. Eligible patients can choose between three-, six- or 12-month subscriptions for the Wegovy injection or the two highest doses of the newly launched pill under the same brand name. Longer plans offer lower monthly pricing, and the company expects people to save up to $1,200 a year on the injection and as much as $600 a year on the pill, relative to paying for their…